Definium Therapeutics Inc (DFTX) PT Raised to $72 at Wells Fargo
Tweet
Share
E-mailGet Alerts DFTX Hot Sheet
Price: $39.28 +1.21%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
Wells Fargo analyst Benjamin Burnett raised the price target on Definium Therapeutics Inc (NASDAQ: DFTX) to $72.00 (from $68.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Adeptus Biotechnologies Corp. (ADPT) PT Raised to $34 at BTIG
- Antero Midstream Partners LP (AM) PT Lowered to $22 at UBS
- Plains All American (PAA) PT Raised to $28 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
